The Parma international randomized study in relapsed non Hodgkin lymphoma: 1st interim analysis of 128 patients (as 15 January 1991: 153 patients)
- PMID: 1878684
The Parma international randomized study in relapsed non Hodgkin lymphoma: 1st interim analysis of 128 patients (as 15 January 1991: 153 patients)
Similar articles
-
Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.Eur J Haematol. 2007 Feb;78(2):93-101. doi: 10.1111/j.1600-0609.2006.00796.x. Eur J Haematol. 2007. PMID: 17313557 Clinical Trial.
-
Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.Cancer Invest. 2008 May;26(4):401-6. doi: 10.1080/07357900701788098. Cancer Invest. 2008. PMID: 18443961
-
Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.Bone Marrow Transplant. 1993 Oct;12(4):337-45. Bone Marrow Transplant. 1993. PMID: 7506091 Clinical Trial.
-
Non-hodgkins lymphoma.Clin Evid. 2003 Jun;(9):1-21. Clin Evid. 2003. PMID: 12967352 Review. No abstract available.
-
[Malignant lymphoma and adult T-cell leukemia-lymphoma].Rinsho Ketsueki. 2014 Feb;55(2):191-200. Rinsho Ketsueki. 2014. PMID: 24598187 Review. Japanese. No abstract available.
Cited by
-
Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?Drugs. 1992 Jul;44(1):1-8. doi: 10.2165/00003495-199244010-00001. Drugs. 1992. PMID: 1379906 Review. No abstract available.
-
High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.Cochrane Database Syst Rev. 2012 Jan 18;1(1):CD007678. doi: 10.1002/14651858.CD007678.pub2. Cochrane Database Syst Rev. 2012. PMID: 22258971 Free PMC article.
-
Predictors of response to axicabtagene-ciloleucel CAR T cells in aggressive B cell lymphomas: A real-world study.J Cell Mol Med. 2022 Dec;26(24):5976-5983. doi: 10.1111/jcmm.17550. Epub 2022 Dec 1. J Cell Mol Med. 2022. PMID: 36453136 Free PMC article.
-
The role of autografting in lymphoma.Postgrad Med J. 1994 Jul;70(825):475-8. doi: 10.1136/pgmj.70.825.475. Postgrad Med J. 1994. PMID: 7937424 Free PMC article. Review. No abstract available.
-
Referral Patterns and Clinical Outcomes for Transplant-Eligible Lymphoma and Myeloma Patients Evaluated at an Urban County Hospital.J Stem Cell Res Ther. 2016;6:328. doi: 10.4172/2157-7633.1000328. Epub 2016 Feb 19. J Stem Cell Res Ther. 2016. PMID: 28966870 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Medical